Image

Strontium-Hydroxyapatite Coated Mini-Screws: Antibacterial Effect and Stability

Strontium-Hydroxyapatite Coated Mini-Screws: Antibacterial Effect and Stability

Recruiting
16-20 years
All
Phase N/A

Powered by AI

Overview

This randomized controlled clinical trial aims to evaluate the antibacterial efficacy and stability of strontium-incorporated hydroxyapatite (Sr-HA) coated orthodontic mini-screws (OMSs) used for maxillary canine retraction. A double-blind, split-mouth design was employed, involving 20 patients (aged 16-20 years), each receiving two titanium alloy mini-screws (1.6 mm × 8 mm): one coated with Sr-HA (5% concentration via electrochemical deposition) and one uncoated control. A total of 40 mini-screws were assessed. Following upper first premolar extractions, canine retraction was initiated using 150 g NiTi coil springs on 17×25 SS archwires. Mini-screws were placed between the upper second premolar and first molar without flap elevation or pilot hole drilling. Parameters including screw stability, antimicrobial activity, and gingival blood flow were monitored over a 4-month period. The incorporation of Sr-HA is hypothesized to enhance mini-screw osseointegration, reduce peri-implant inflammation, and improve clinical outcomes by leveraging the osteogenic and antibacterial properties of strontium. This study aims to provide evidence supporting the use of Sr-HA coatings to reduce mini-screw failure rates in orthodontic treatment.

Description

Aim of the study:

The aim of this study is to evaluate the antibacterial efficacy and stability of strontium- incorporated hydroxyapatite (Sr-HA) coated orthodontic mini- screws used in maxillary canine retraction in comparison to uncoated mini- screws.

Material and methods:

  1. All patients will be treatment with fixed appliance and Roth type brackets where leveling and alignment will be done utilizing nickel titanium.
  2. Extraction the upper first premolars and retraction the canine will be done using 17 ×25 SS wire.
  3. A periapical X-ray will be taken to confirm the mini screw position to avoid interference with adjacent root and to ensure that there are no periapical lesion.
  4. Symmetrical orthodontic miniscrews will be inserted between the second premolar and first molar.
  5. The OMSs that will be used in this study will be self-drilling, conical in shape, 1.6 mm in diameter, and 8 mm in length, constructed of titanium alloy, i well be purchased from Dentaurum company [Germany].
  6. The orthodontic main screws were loaded with a 150 g NiTi coil spring.
  7. On one side, a coated will be inserted, and on the other side, an uncoated will be used for the same patient.
  8. Coated materials will utilize [Strontium incorporated hydroxyapatite] applied by electrochemical deposition and concentration percentage about 5 % .
  9. No mucoperiosteal flap will be raised, and no pilot hole will be made during the procedure.
  10. Will be assessed throughout follow-up periods of up to four months.

Outcome Measurement:

  1. Assessment Orthodontic mini-screws stability (coated and uncoated) using Periotest device .
  2. Evaluate antimicrobial effect of Strontium incorporated Hydroxyapatite using EnzemLinked Immunosorbent technique .
  3. Evaluate blood flow by periodental probe.
  4. Gingival health by visual assessment .

Eligibility

Inclusion Criteria:

  1. Adult patients within an age range (16-20) years.
  2. Orthodontic treatment plan requiring the extraction of the upper first premolars.
  3. Patients have fully permanent teeth are erupted (third molars are not included).
  4. No previous orthodontic treatment
  5. No medical problem that could interfere with treatment.

Exclusion Criteria:

  1. Presence of problematic healing such as, compromised immune defense, bleeding disorder, pathological bone quality, and xerostomia.
  2. Inadequate oral hygiene.
  3. Heavy smoking

Study details
    Evaluate the Antibacterial Efficacy and Stability of Strontium-incorporated Hydroxyapatite Coatings on Orthodontic Mini-screw ; Clinical t

NCT07105969

Mansoura University

15 August 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.